213 related articles for article (PubMed ID: 34103603)
21. Pro re nata anti-VEGF treatment in pachychoroid neovasculopathy compared with age-related macular degeneration based on optical coherence tomography.
Üney G; Hazırolan D; Ünlü N; Candan Ö
Int Ophthalmol; 2024 Mar; 44(1):164. PubMed ID: 38551696
[TBL] [Abstract][Full Text] [Related]
22. Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration.
Terao N; Koizumi H; Kojima K; Yamagishi T; Yamamoto Y; Yoshii K; Kitazawa K; Hiraga A; Toda M; Kinoshita S; Sotozono C; Hamuro J
Sci Rep; 2018 Jul; 8(1):10520. PubMed ID: 30002400
[TBL] [Abstract][Full Text] [Related]
23. An efficacy comparison of combination of different anti-vascular endothelial growth factors and photodynamic therapy in patients with pachychoroid neovasculopathy.
Karasu B; Celebi ARC
Int Ophthalmol; 2021 Jun; 41(6):1989-2000. PubMed ID: 33651313
[TBL] [Abstract][Full Text] [Related]
24. Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy.
Matsumoto H; Hoshino J; Mukai R; Nakamura K; Akiyama H
Sci Rep; 2021 Mar; 11(1):6759. PubMed ID: 33762600
[TBL] [Abstract][Full Text] [Related]
25. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
Shin JY; Kwon KY; Byeon SH
Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal Aflibercept and Ranibizumab Injections for Polypoidal Choroidal Vasculopathy.
Cho HJ; Kim KM; Kim HS; Han JI; Kim CG; Lee TG; Kim JW
Am J Ophthalmol; 2016 May; 165():1-6. PubMed ID: 26921806
[TBL] [Abstract][Full Text] [Related]
27. Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept.
Kaya F
J Fr Ophtalmol; 2017 Dec; 40(10):832-838. PubMed ID: 29113742
[TBL] [Abstract][Full Text] [Related]
28. Different Outcomes of Anti-VEGF Treatment for Neovascular AMD according to Neovascular Sutypes and Baseline Features: 2-Year Real-Life Clinical Outcomes.
Arrigo A; Saladino A; Aragona E; Mercuri S; Introini U; Bandello F; Parodi MB
Biomed Res Int; 2021; 2021():5516981. PubMed ID: 34124243
[TBL] [Abstract][Full Text] [Related]
29. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
[TBL] [Abstract][Full Text] [Related]
30. INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB INJECTIONS FOR TYPE 3 NEOVASCULARIZATION.
Cho HJ; Hwang HJ; Kim HS; Han JI; Lee DW; Kim JW
Retina; 2018 Nov; 38(11):2150-2158. PubMed ID: 28984737
[TBL] [Abstract][Full Text] [Related]
31. Real-World Treatment Outcomes of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asians.
Fenner BJ; Ting DSW; Tan ACS; Teo K; Chan CM; Mathur R; Yeo IYS; Wong TY; Wong EYM; Cheung CMG
Ophthalmol Retina; 2020 Apr; 4(4):403-414. PubMed ID: 31953109
[TBL] [Abstract][Full Text] [Related]
32. Ranibizumab for vascularized pigment epithelial detachment: 1-year anatomic and functional results.
Chevreaud O; Oubraham H; Cohen SY; Jung C; Blanco-Garavito R; Gherdaoui F; Souied EH
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):743-751. PubMed ID: 27913869
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps.
Kim JH; Lee DW; Choi SC; Kim JW; Lee TG; Kim CG; Cho HJ
Korean J Ophthalmol; 2015 Dec; 29(6):404-10. PubMed ID: 26635457
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
Komuku Y; Iwahashi C; Gomi F
Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
[TBL] [Abstract][Full Text] [Related]
35. Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy.
Nagai N; Suzuki M; Minami S; Kurihara T; Kamoshita M; Sonobe H; Watanabe K; Uchida A; Shinoda H; Tsubota K; Ozawa Y
Sci Rep; 2019 Aug; 9(1):11389. PubMed ID: 31388029
[TBL] [Abstract][Full Text] [Related]
36. Subfoveal Choroidal Thickness in Eyes with Neovascular Age-Related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents.
Kanadani TCM; Veloso CE; Nehemy MB
Ophthalmologica; 2018; 240(4):200-207. PubMed ID: 29768266
[TBL] [Abstract][Full Text] [Related]
37. Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration.
Tanaka A; Hata M; Tsuchikawa M; Ueda-Arakawa NU; Tamura H; Miyata M; Takahashi A; Kido A; Muraoka Y; Miyake M; Ooto S; Tsujikawa A
Clin Ophthalmol; 2024; 18():507-516. PubMed ID: 38405104
[TBL] [Abstract][Full Text] [Related]
38. A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom.
Johnston RL; Carius HJ; Skelly A; Ferreira A; Milnes F; Mitchell P
Adv Ther; 2017 Mar; 34(3):703-712. PubMed ID: 28144918
[TBL] [Abstract][Full Text] [Related]
39. Comparison of visual outcomes of polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration-up to 10 years of follow-up.
Park JY; Park YJ; Park SJ; Park KH; Yeo JH; Kim JG; Yoon YH; Lee JY; Woo SJ
Acta Ophthalmol; 2022 Dec; 100(8):e1579-e1588. PubMed ID: 35363434
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]